Aim Telomere shortening has been reported in several diseases including atherosclerosis and Type 1 diabetes. Asian Indians have an increased predilection for Type 2 diabetes and premature coronary artery disease. The aim of this study was to determine whether telomeric shortening occurs in Asian Indian Type 2 diabetic patients.
Introduction
Telomeres, the TTAGGG tandem repeats at the ends of mammalian chromosomes, undergo attrition with each division of somatic cells in culture, and hence their length is an indicator of the replicative potential of these cells [1] . The inability of DNA polymerases to replicate a linear DNA molecule to its very end [2] and the action of a strand-specific exonuclease [3] are believed to contribute to the shortening of telomeres. Increased oxygen tension has also been shown to accelerate telomere shortening in replicating fibroblasts in vitro [4] . Telomeric DNA sequences appear to be particularly prone to chromosomal breakage [5] , and their GGG-triplets are a major target for reactive oxygen species [6 -8] .
Recent studies have demonstrated that telomere shortening is related to various pathological conditions including atherosclerosis [9] [10] [11] [12] . Jeanclos et al . [13] established an association between telomere shortening in white blood cells (WBCs) and Type 1, but not in Type 2, diabetic patients of European origin. Asian Indian Type 2 diabetic patients differ from Europeans in several aspects: the onset of diabetes occurs at a younger age [14] , and there is a greater degree of hyperinsulinaemia [15] and insulin resistance [16] . In addition they have very high prevalence rates of premature coronary artery disease [17, 18] .
In this paper we report that telomere lengths are shortened in urban southern Indian Type 2 diabetic patients. This is the first report, to our knowledge, of telomere shortening in Type 2 diabetes.
Subjects and methods

Sample selection
The Chennai Urban Rural Epidemiology Study (CURES) is an ongoing epidemiological study conducted on a representative population of Chennai (formerly Madras), the fourth largest city in India with a population of approximately 4.2 million. The methodology of the study has been published elsewhere [19, 20] . Briefly, in Phase 1 of the urban component of CURES, 26 001 individuals were recruited based on a systematic random sampling technique. Self-reported diabetic subjects were classified as 'known diabetic subjects'.
In Phase 2 of CURES, all known diabetic subjects ( n = 1529) were invited to our centre for detailed studies on vascular complications. In addition, age-and sex-matched non-diabetic subjects underwent oral glucose tolerance tests (OGTT) using 75 g of glucose load. Those who were confirmed by OGTT to have fasting venous plasma glucose < 6.1 mmol / l and a 2-h plasma glucose value < 7.8 mmol / l were categorized as normal glucose tolerance (NGT). For the present study we randomly selected 40 diabetic subjects without any complications (using computer-generated random numbers) and 40 age-and sexmatched subjects with NGT. The study had a power of 80% to detect a statistically significant ( P = 0.05) difference of 2.0 kb in TRF between the two study groups.
Physical examination included height, weight, waist and hip measurements using standardized techniques. Blood pressure was recorded in the right arm with a mercury sphygmomanometer (Diamond Deluxe Blood Pressure Apparatus, Pune, India) while the patients were seated. Two readings were taken 5 min apart and the mean of the two was taken as the blood pressure. A fasting blood sample was taken, and serum separated and stored at − 70 ° C until the assays were performed. Biochemical analyses were carried out on a Hitachi-912 Autoanalyser (Hitachi, Mannheim, Germany) using kits supplied by Roche Diagnostics (Mannheim, Germany). Fasting plasma glucose (GOD-POD method), serum cholesterol (CHOD-PAP method), serum triglycerides (GPO-PAP method) and HDL cholesterol (direct method-polyethylene glycol-pretreated enzymes) were measured. Low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald formula [21] . Glycated haemoglobin (HbA 1c ) was estimated by high-pressure liquid chromatography using the Variant machine (Bio-Rad, Hercules, CA, USA). Serum insulin concentration was estimated using Dako kits (Dako, Glostrup, Denmark). Insulin resistance (HOMA-IR) was calculated using the Homeostasis Model Assessment using the formula: fasting insulin ( µ IU/ml) × fasting glucose (mmol/l)/22.5 [22] . Informed consent was obtained from all study subjects, and the study was approved by the institutional Ethics Committee.
To avoid the confounding effect of diabetic complications on telomeric shortening, the diabetic subjects selected had no evidence of retinopathy (assessed by retinal photography) or nephropathy (24-h protein excretion < 100 mg/day and urinary albumin levels < 30 µ g/mg creatinine). They also had no history of angina or myocardial infarction, and a normal 12-lead resting ECG. Hypertension was diagnosed if the subjects had been treated with antihypertensive drugs or had systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg.
TRF length analysis
Genomic DNA was prepared from whole blood by digestion with proteinase-K and extraction with phenol/chloroform and was quantified spectrophotometrically. The DNA samples extracted from WBCs were coded, and only after completion of the TRF measurement was the code broken for data analysis. Terminal restriction fragment (TRF) lengths were measured using the Southern-blotting technique [13] . Briefly, equal amounts of DNA (2 µ g) were digested with restriction enzymes HinfI (20 U) and RsaI (20 U) (Roche Diagnostics) for 2 h at 37 ° C to liberate TRFs, which include both subtelomeric repetitive DNA and telomeric TTAGGG repeats. The TRFs that determines the telomere lengths were separated by electrophoresis on 0.8% agarose gel denatured with 0.5 M NaOH/1.5 M NaCl and neutralized for 30 min in 0.5 M Tris and 1.5 M NaCl. The DNA was transferred overnight to a nylon membrane positively charged using capillary transfer. The membranes were then hybridized with telomeric probe digoxigenin 3 ′ end labelled 5 ′ -(CCCTAA) 3 for 3 h in the hybridization solution. They were then washed at room temperature, three times in 2 × saline sodium citrate (SSC), 0.1% SDS each for 15 min and once in 2 × SSC for 15 min. The digoxigenin-labelled probe was detected by the digoxigenin luminescent detection procedure and exposed on X-ray film. The mean TRF length was determined using automated BIORAD Gel documentation software and calculated as follows: TRF = Σ ODi/( Σ ODi/ Σ MWi), where ODi is the optical density at a given position in the lane and MWi is the molecular weight at that position; this formula [23] accounts for the fact that longer telomeres bind more labelled probes and consequently appear darker on the X-ray film (Fig. 1) . Proper reference standards and molecular-weight markers were included in all blots. To show the reproducibility of our method, we measured the telomere lengths of eight subjects on two different occasions. For this, blood samples were taken twice from the same subject on two different occasions and the respective DNA used for the TRF length measurements were referred to as TRF1 and TRF2. As shown in Fig. 2 , the two values correlated well ( r = 0.93; P < 0.001), indicating that white blood cell mean TRF length is a reproducible measure. The interassay coefficient of variation was < 3% and the maximum difference between the two blots carried out from the same subject on different days (blot-to-blot variability) was < 7%, i.e. < 0.5 kb.
Lipid peroxidation
Plasma levels of malondialdehyde (MDA), a marker of lipid peroxidation, were measured by TBARS (thiobarbituric acid reactive substances) by fluorescence methodology [24] . Plasma (200 µ l) was treated with 8.1% SDS and 20% acetic acid to solubilize and precipitate protein and then heated with TBA for 1 h at 95 ° C. The supernatant was then extracted with butanol:pyridine (15 : 1), to produce a fluorescent product, which was detected by excitation at 535 nm and emission at 553 nm. Absolute MDA (malonodialdehyde) levels were calculated using the regression parameters obtained using various concentrations (0.25 -5.0 nM) of the standard, 1,1 ′ ,3,3 ′ ,-tetramethoxypropane. Inter-and intra-assay coefficients of variation of the above method were < 5 and 10%, respectively.
Statistical analysis
Comparisons between groups were performed using an unpaired Student's t -test. Two-tailed P -values equal to or less than 0.05 were considered statistically significant. Pearson correlation analysis was performed between variables. Risk variables that had a significant association with TRF on univariate regression were included as independent variables in multiple linear regression analysis. Care was taken to avoid intercorrelated variables in the regression equation. All analyses were carried out using a Windows-based SPSS statistical package (Version 10.0, Chicago, IL, USA). Table 1 shows the characteristics of both the diabetic and nondiabetic subjects. None of the diabetic patients had ketonuria or any history of diabetic ketosis at any time and all were treated with oral agents sulphonylurea (glipizide or glibenclamide) and / or metformin. Hence they all had Type 2 diabetes. Diabetic patients had significantly higher plasma glucose, HbA 1c , serum cholesterol, triglycerides and HOMA-IR compared with the control subjects.
Results
The mean ( ± SE) TRF lengths were significantly lower in the patients with Type 2 diabetes (6.01 ± 0.2; range 3.0 -9.5 kb) compared with the control subjects (9.11 ± 0.6; range 3.5-15.8 kb) ( P = 0.0001) (Fig. 3) . Age-adjusted telomere lengths were significantly shorter in men (7.69 ± 0.6) than in women (10.42 ± 1.0) ( P = 0.02) in the control subjects. This gender difference in TRF length was not observed among the diabetic subjects (men 5.81 ± 0.4, women 6.22 ± 0.3, P = 0.51). When compared with the diabetic subjects without hypertension (6.74 ± 0.3) the diabetic subjects with hypertension exhibited significantly shorter TRF lengths (5.23 ± 0.4) ( P = 0.007).
Lipid peroxidation as measured by TBARS was significantly higher in the patients with Type 2 diabetes (9.69 ± 1.0 nM / ml) when compared with the control subjects (6.17 ± 0.3 nM / ml) (Fig. 4a) . Increased levels of TBARS also showed a negative correlation with shortened telomeres in the diabetic subjects ( r = − 0.36; P = 0.02) (Fig. 4b) . However, such a relationship 
Figure 2
Reproducibility of mean telomere restriction fragment (TRF) length assay. Blood samples were taken twice from the same subject on two different occasions and the respective DNA was used for the determination of telomere lengths (referred as TRF1 and TRF2). Excellent correlation (r = 0.93; P = 0.001) between these two measurements obtained from eight individuals. between TBARS and TRF was not observed in the control group.
Telomere lengths were negatively correlated with insulin resistance (HOMA-IR) ( r = − 0.4; P = 0.01) and age (r = −0.3; P = 0.058) and positively correlated with HDL levels (r = 0.4; P = 0.01) in the control subjects. Correlation of TRF lengths with HbA 1c levels (r = −0.28; P = 0.01) and cholesterol to HDL ratio (r = −0.31; P = 0.005) was obvious only in the total study subjects. Multiple linear regression analysis carried out using diabetes status, cholesterol to HDL ratio and TBARS as independent variables revealed the presence of diabetes as the sole risk factor associated with telomere shortening (β = −2.71, P < 0.0001).
Discussion
Shortening of telomeres has been reported to be present in patients with inherited respiratory chain disorders [25] , Down's syndrome [26] , vascular dementia [27] and ataxia-telangiectasia [28] . Recent studies have also shown that telomere shortening can be a biomarker of premature cell senescence in vascular diseases and metabolic disorders [10, 11, 12] .
An earlier study from the USA demonstrated telomere shortening in Type 1, but not in Type 2 diabetic patients of European descent [13] . Our study is the first to demonstrate a shortened TRF length in WBCs in patients with Type 2 diabetes. It is possible that the increased insulin resistance observed in Asian Indians [16] contributes to the telomere shortening observed in our patients. This is supported by the association of the telomere shortening with HOMA-IR observed in this study. Our results also indicate the presence of diabetes as one of the risk factors associated with telomere shortening. It is possible that chronic hyperglycaemia and associated oxidative stress may modify TRF length in WBCs. Alternatively, a diminished TRF length could be a secondary phenomenon arising out of accelerated telomere attrition owing to an increased turnover and chronic activation of inflammatory cells.
In non-diabetic subjects, the age-adjusted telomere length is shorter in men than in women, confirming earlier studies [29] [30] [31] . As premenopausal women are less prone than men to cardiovascular diseases [32] and several systemic parameters show poor correlation with blood pressure in women [33] , our observations suggest that the biology of ageing differs between men and women. Moreover, an oestrogen-responsive element is present in hTERT [34] , and hence hormonal changes may influence telomerase to maintain the telomere length in women. However, this gender difference was absent in Type 2 diabetic subjects. It is well known that women with Type 2 diabetes lose their protection from coronary artery disease [35] . Our study confirms these findings using TRF as a marker.
Within the diabetic subjects, those with hypertension also showed a significantly reduced TRF length when compared with subjects without hypertension. Hypertensive subjects are at higher risk for atherosclerosis and accelerated cardiovascular ageing [30] . Increased oxidative stress has been considered as one of the molecular determinants of cardiovascular diseases [36] . Therefore telomere length may provide an additional link between oxidative stress and the predisposition to cardiovascular disease in hypertensive subjects.
The association of short telomeres with insulin resistance (as measured by HOMA-IR) and cholesterol to HDL ratio suggests that telomere shortening could probably be used as an additional marker of atherosclerosis. In support of this, coronary artery disease patients have been shown to exhibit telomere shortening [11] . Asian Indians have high prevalence rates of premature coronary artery disease [17, 18, 37] . The excess risk for coronary artery disease seen among Asian Indians has hitherto not been explained by any of the conventional risk factors. From this study one could speculate that telomere attrition could be one of the molecular mechanisms that predispose Asian Indian diabetic patients to premature coronary artery disease. However, further work needs to be performed on diabetic patients with and without coronary artery disease to confirm this hypothesis. It is also known that several additional factors such as oxygen-free radicals and elevated plasma homocysteine, which are overproduced in some metabolic diseases, are responsible for DNA damage and telomere shortening, and can induce atherosclerosis [8,38 -40] . The positive association of HDL cholesterol and TRF length in our study also lends further support to this hypothesis. Interestingly it was recently shown that increased HDL cholesterol and TRF were linked to increased longevity even in animal models [41] [42] [43] .
The association of increased lipid peroxidation (TBARS) with shorter telomeres in our study may indicate a role for reactive oxygen species in telomere shortening. Schisterman et al. [44] have shown that individuals with coronary heart disease had significantly higher levels of TBARS and lipid peroxidation was found to be the best discriminator when the biomarkers of oxidative stress were evaluated individually. Studies in cultured cells have shown that telomere erosion per replication is inversely related to antioxidant capacity [4, 45, 46] . Inflammation and ROS thus appear to be important factors in the pathobiology of age-related disorders, including Type 2 diabetes [47, 48] . As suggested by Furumoto et al. [49] telomere length registers the turnover rate of cells, including WBC, a rate that may be augmented by chronic inflammation, and an increase in the cumulative oxidative stress. We found a good correlation between TBARS and telomere shortening. However, in our multiple linear regression model diabetes was the only significant factor in determining telomere shortening, and addition of TBARS did not affect this relationship. This may be explained by the fact that in diabetes, oxidative stress appears as an early biochemical defect and thus further addition of TBARS into the model only had minimal influence.
In summary, we report that telomere shortening of WBCs is observed in Asian Indian patients with Type 2 diabetes. Oxidative stress could be a common molecular mechanism in which the expression of genes related to glucose metabolism, lipid metabolism and vascular function are modified in subjects with diabetes. As telomere length is also highly heritable [29, 50] , and probably X-linked in some cases [31] , the role of genetic predisposition to shortened telomeres in chronic age-related disorders needs further investigation. Telomeres shorten very slowly with age, raising the exciting possibility that telomere shortening may be a risk marker of diabetes and its vascular complications. Future studies are needed to look at telomere shortening in diabetic micro-and macro-vascular complications, and also into whether the shortening can be reversed, at least in part, by tight control of diabetes.
